Loading…
A Dual‐Functional Persistently Luminescent Nanocomposite Enables Engineering of Mesenchymal Stem Cells for Homing and Gene Therapy of Glioblastoma
Therapeutically engineered mesenchymal stem cells (MSC) have shown promising capability for glioblastoma (GBM) therapy; however, simultaneous tracking of their migration and long‐term fate is urgently needed for clinical application. This study shows the design and fabrication of a dual‐functional p...
Saved in:
Published in: | Advanced functional materials 2017-03, Vol.27 (11), p.np-n/a |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Therapeutically engineered mesenchymal stem cells (MSC) have shown promising capability for glioblastoma (GBM) therapy; however, simultaneous tracking of their migration and long‐term fate is urgently needed for clinical application. This study shows the design and fabrication of a dual‐functional persistent luminescence nanocomposite (LPLNP‐PPT/TRAIL) for effective therapeutic engineering and tracking of MSC in the meantime. LPLNP‐PPT/TRAIL shows low‐toxicity, near‐infrared persistent luminescence emitting without in situ excitation, and superior in vivo deep brain tissue imaging, which can efficiently track the tumortropic migration of the therapeutic engineered MSC. Both in vitro and in vivo findings demonstrate the feasibility of LPLNP‐PPT/TRAIL engineered MSC for inducing apoptosis of glioblastoma cells. This work first establishes an LPLNP‐based dual‐functional platform for cell engineering and provides us implications for GBM‐related diagnosis and therapy.
A dual‐functional persistently luminescent nanocomposite (LPLNP‐PPT/TRAIL) with good biocompatibility, capable of emitting near‐infrared persistent luminescence without in situ excitation, is developed. Superior in vivo deep brain tissue imaging using this nanocomposite allows for effective therapeutic engineering and tracking of mesenchymal stem cells (MSC) in a glioblastoma (GBM) model. The engineered therapeutic and diagnostic MSC are promising for GBM‐related diagnosis and therapy. |
---|---|
ISSN: | 1616-301X 1616-3028 |
DOI: | 10.1002/adfm.201604992 |